Menu
Currency
GWAS Study

A genome-wide screening and SNPs-to-genes approach to identify novel genetic risk factors associated with frontotemporal dementia.

Ferrari R, Grassi M, Salvi E et al.

26154020 PubMed ID
GWAS Study Type
1456 Participants
30 Views
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

FR
Ferrari R
GM
Grassi M
SE
Salvi E
BB
Borroni B
PF
Palluzzi F
PD
Pepe D
DF
D'Avila F
PA
Padovani A
AS
Archetti S
RI
Rainero I
RE
Rubino E
PL
Pinessi L
BL
Benussi L
BG
Binetti G
GR
Ghidoni R
GD
Galimberti D
SE
Scarpini E
SM
Serpente M
RG
Rossi G
GG
Giaccone G
TF
Tagliavini F
NB
Nacmias B
PI
Piaceri I
BS
Bagnoli S
BA
Bruni AC
MR
Maletta RG
BL
Bernardi L
PA
Postiglione A
MG
Milan G
FM
Franceschi M
PA
Puca AA
NV
Novelli V
BC
Barlassina C
GN
Glorioso N
MP
Manunta P
SA
Singleton A
CD
Cusi D
HJ
Hardy J
MP
Momeni P
Chapter II

Abstract

Summary of the research findings

Frontotemporal dementia (FTD) is the second most prevalent form of early onset dementia after Alzheimer's disease (AD). We performed a case-control association study in an Italian FTD cohort (n = 530) followed by the novel single nucleotide polymorphisms (SNPs)-to-genes approach and functional annotation analysis. We identified 2 novel potential loci for FTD. Suggestive SNPs reached p-values ∼10(-7) and odds ratio > 2.5 (2p16.3) and 1.5 (17q25.3). Suggestive alleles at 17q25.3 identified a disease-associated haplotype causing decreased expression of -cis genes such as RFNG and AATK involved in neuronal genesis and differentiation and axon outgrowth, respectively. We replicated this locus through the SNPs-to-genes approach. Our functional annotation analysis indicated significant enrichment for functions of the brain (neuronal genesis, differentiation, and maturation), the synapse (neurotransmission and synapse plasticity), and elements of the immune system, the latter supporting our recent international FTD-genome-wide association study. This is the largest genome-wide study in Italian FTD to date. Although our results are not conclusive, we set the basis for future replication studies and identification of susceptible molecular mechanisms involved in FTD pathogenesis.

530 European ancestry cases, 926 European ancestry controls

Chapter III

Study Statistics

Key metrics and study information

1456
Total Participants
GWAS
Study Type
No
Replicated
European
Ancestry
Italy
Recruitment Country
Chapter IV

AI-Generated Summary

AI-generated by DNAGENICS

Independent AI summary of health and genetic findings from the published study

Important: This summary is AI-generated by DNAGENICS for informational purposes only. It was not created by, affiliated with, or endorsed by the researchers behind the original publication, and is based solely on that published research. It may contain errors or omissions. DNAGENICS disclaims all liability for any inaccuracies or consequences arising from use of this information. Verify all information against the original publication. This is not professional scientific review or medical advice.

AI Summary In Progress

Our AI-generated summary of this publication is being prepared. Please check back soon.